Vanguard Personalized Indexing Management, LLC Vaxcyte, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 6,620 shares of PCVX stock, worth $475,978. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,620
Previous 6,716
1.43%
Holding current value
$475,978
Previous $766,000
29.37%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding PCVX
# of Institutions
350Shares Held
126MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$860 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$760 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$715 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$625 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$447 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.26B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...